Aclaris Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BML CAPITAL MANAGEMENT, LLC | 05/07/2025 | 14.25 M | $21.80 M | 0.00% | 11.64% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 05/15/2025 | 9.63 M | $14.73 M | 0.00% | 7.87% |
| VIVO CAPITAL, LLC | 05/12/2025 | 8.89 M | $13.60 M | 0.00% | 7.26% |
| VANGUARD GROUP INC | 05/09/2025 | 4.97 M | $7.60 M | 14.91% | 4.06% |
| RA CAPITAL MANAGEMENT, L.P. | 05/15/2025 | 4.67 M | $7.14 M | 0.00% | 3.81% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2025 | 4.13 M | $6.33 M | 111.03% | 3.38% |
| DECHENG CAPITAL LLC | 05/08/2025 | 4.04 M | $6.18 M | 78.31% | 3.30% |
| D. E. SHAW & CO., INC. | 05/15/2025 | 2.94 M | $4.51 M | -10.60% | 2.41% |
| MORGAN STANLEY | 05/15/2025 | 2.42 M | $3.70 M | 125.38% | 1.97% |
| MARSHALL WACE, LLP | 05/15/2025 | 2.31 M | $3.54 M | -12.19% | 1.89% |
| ACADIAN ASSET MANAGEMENT LLC | 05/21/2025 | 2.20 M | $3.36 M | 25.86% | 1.79% |
| BOLLARD GROUP LLC | 05/15/2025 | 1.42 M | $2.18 M | 100.00% | 1.16% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 1.38 M | $2.11 M | 1,648.00% | 1.13% |
| BLACKROCK, INC. | 05/02/2025 | 1.36 M | $2.08 M | 8.21% | 1.11% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 05/15/2025 | 1.35 M | $2.07 M | 119.62% | 1.10% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 1.18 M | $1.81 M | 49.79% | 0.97% |
| CITADEL ADVISORS LLC | 05/15/2025 | 1.12 M | $1.72 M | 1,927.36% | 0.92% |
| ALDEBARAN CAPITAL, LLC | 05/13/2025 | 1.01 M | $1.54 M | -0.89% | 0.82% |
| RENAISSANCE TECHNOLOGIES LLC | 05/14/2025 | 951.39 K | $1.46 M | 11.86% | 0.78% |
| DEUTSCHE BANK AG\ | 05/09/2025 | 923.31 K | $1.41 M | 0.00% | 0.75% |
| MONASHEE INVESTMENT MANAGEMENT LLC | 05/14/2025 | 888.89 K | $1.36 M | 0.00% | 0.73% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 05/12/2025 | 865.01 K | $1.32 M | -4.82% | 0.71% |
| TWO SIGMA ADVISERS, LP | 05/15/2025 | 858.40 K | $1.31 M | -12.18% | 0.70% |
| TWO SIGMA INVESTMENTS, LP | 05/15/2025 | 820.26 K | $1.26 M | -2.26% | 0.67% |
| PALO ALTO INVESTORS LP | 05/15/2025 | 776.03 K | $1.19 M | 36.19% | 0.63% |
| CANTOR FITZGERALD, L. P. | 05/15/2025 | 695.57 K | $1.06 M | 595.57% | 0.57% |
| ASSENAGON ASSET MANAGEMENT S.A. | 04/15/2025 | 681.55 K | $1.04 M | 71.52% | 0.56% |
| GOLDMAN SACHS GROUP INC | 06/27/2025 | 555.95 K | $850.61 K | 29.72% | 0.45% |
| STONEPINE CAPITAL MANAGEMENT, LLC | 05/14/2025 | 527.84 K | $2.77 M | -20.43% | 0.43% |
| JPMORGAN CHASE & CO | 05/12/2025 | 498.72 K | $763.04 K | 464.68% | 0.41% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 05/15/2025 | 460.84 K | $705.09 K | -20.00% | 0.38% |
| FMR LLC | 05/12/2025 | 458.18 K | $701.02 K | -0.19% | 0.37% |
| AISLING CAPITAL MANAGEMENT LP | 05/13/2025 | 434.46 K | $664.72 K | 0.00% | 0.36% |
| STATE STREET CORP | 05/15/2025 | 407.53 K | $623.51 K | 27.64% | 0.33% |
| JANE STREET GROUP, LLC | 05/19/2025 | 390.28 K | $597.13 K | -28.46% | 0.32% |
| DIMENSIONAL FUND ADVISORS LP | 05/13/2025 | 354.85 K | $543.26 K | 48.10% | 0.29% |
| SQUAREPOINT OPS LLC | 05/15/2025 | 348.92 K | $533.84 K | 19.13% | 0.29% |
| HIGHTOWER ADVISORS, LLC | 05/13/2025 | 316.06 K | $483.58 K | 20.20% | 0.26% |
| WALLEYE CAPITAL LLC | 05/14/2025 | 311.71 K | $476.92 K | -56.64% | 0.25% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 05/15/2025 | 288.72 K | $441.74 K | 2.70% | 0.24% |
| NORTHERN TRUST CORP | 05/13/2025 | 269.09 K | $411.70 K | 53.61% | 0.22% |
| RAYMOND JAMES FINANCIAL INC | 05/13/2025 | 250.81 K | $383.73 K | 62.49% | 0.20% |
| MAN GROUP PLC | 05/15/2025 | 197.75 K | $302.55 K | 269.39% | 0.16% |
| GRAHAM CAPITAL MANAGEMENT, L.P. | 05/15/2025 | 177.56 K | $271.66 K | 1,152.88% | 0.15% |
| OMERS ADMINISTRATION CORP | 05/14/2025 | 175.90 K | $269.13 K | 223.35% | 0.14% |
| BANK OF AMERICA CORP /DE/ | 05/15/2025 | 167.67 K | $256.53 K | -18.40% | 0.14% |
| IKARIAN CAPITAL, LLC | 05/15/2025 | 150.90 K | $230.88 K | -56.89% | 0.12% |
| SCHONFELD STRATEGIC ADVISORS LLC | 05/15/2025 | 127.59 K | $195.22 K | -3.26% | 0.10% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 05/14/2025 | 123.10 K | $189.00 K | 0.00% | 0.10% |
| BARCLAYS PLC | 05/15/2025 | 119.00 K | $182.00 K | 682.85% | 0.10% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Aclaris Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 142 institutional investors and hedge funds held shares of Aclaris Therapeutics, Inc.. The most heavily invested institutionals were:
BML Capital Management, LLC: 14.25 M
ADAGE CAPITAL PARTNERS GP, L.L.C.: 9.63 M
Vivo Capital, LLC: 8.89 M
VANGUARD GROUP INC: 4.97 M
RA CAPITAL MANAGEMENT, L.P.: 4.67 M
MILLENNIUM MANAGEMENT LLC: 4.13 M
69.80% of Aclaris Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 92.44 M shares in the last 24 months. This purchase volume represents approximately $133.11 M in transactions.